Ravulizumab Plus Best Supportive Care in Pediatric Patients with Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy: 52-Week Results from a phase 3 Trial
Fields of Study & Subjects
Complement system in diseases
Renal Diseases and Glomerulopathies
Coagulation
Bradykinin
Polyphosphates
and Angioedema
Publication details
- Journal / source
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Volume
- 32
- Issue
- 2
- Pages
- S69–S70
- Publication date
- 1 February 2026
- Language
- EN